108 related articles for article (PubMed ID: 1893911)
1. Bradykinin agonist activity of a novel, potent oxytocin antagonist.
Pettibone DJ; Clineschmidt BV; Lis EV; Ransom RW; Totaro JA; Young GS; Bock MG; Freidinger RM; Veber DF; Williams PD
Eur J Pharmacol; 1991 Apr; 196(3):233-7. PubMed ID: 1893911
[TBL] [Abstract][Full Text] [Related]
2. In vitro pharmacological profile of a novel structural class of oxytocin antagonists.
Pettibone DJ; Clineschmidt BV; Lis EV; Reiss DR; Totaro JA; Woyden CJ; Bock MG; Freidinger RM; Tung RD; Veber DF
J Pharmacol Exp Ther; 1991 Jan; 256(1):304-8. PubMed ID: 1988661
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948.
Clineschmidt BV; Pettibone DJ; Reiss DR; Lis EV; Haluska GJ; Novy MJ; Cook MJ; Cukierski MA; Kaufman MJ; Bock MG
J Pharmacol Exp Ther; 1991 Mar; 256(3):827-32. PubMed ID: 2005582
[TBL] [Abstract][Full Text] [Related]
4. A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensis.
Pettibone DJ; Clineschmidt BV; Anderson PS; Freidinger RM; Lundell GF; Koupal LR; Schwartz CD; Williamson JM; Goetz MA; Hensens OD
Endocrinology; 1989 Jul; 125(1):217-22. PubMed ID: 2544402
[TBL] [Abstract][Full Text] [Related]
5. Identification of an orally active, nonpeptidyl oxytocin antagonist.
Pettibone DJ; Clineschmidt BV; Kishel MT; Lis EV; Reiss DR; Woyden CJ; Evans BE; Freidinger RM; Veber DF; Cook MJ
J Pharmacol Exp Ther; 1993 Jan; 264(1):308-14. PubMed ID: 8423533
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural product.
Williams PD; Bock MG; Tung RD; Garsky VM; Perlow DS; Erb JM; Lundell GF; Gould NP; Whitter WL; Hoffman JB
J Med Chem; 1992 Oct; 35(21):3905-18. PubMed ID: 1331448
[TBL] [Abstract][Full Text] [Related]
7. Identification of functional oxytocin receptors in lactating rat mammary gland in vitro.
Pettibone DJ; Woyden CJ; Totaro JA
Eur J Pharmacol; 1990 Apr; 188(4-5):235-41. PubMed ID: 2163875
[TBL] [Abstract][Full Text] [Related]
8. 1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm labor.
Williams PD; Anderson PS; Ball RG; Bock MG; Carroll L; Chiu SH; Clineschmidt BV; Culberson JC; Erb JM; Evans BE
J Med Chem; 1994 Mar; 37(5):565-71. PubMed ID: 8126695
[TBL] [Abstract][Full Text] [Related]
9. Oxytocin- and vasopressin-binding sites in the rat uterus: competition binding and inhibitory pA2 studies with oxytocin and oxytocin antagonists.
Chan WY; Cao L; Hill PS; Hruby VJ
Endocrinology; 1990 Apr; 126(4):2095-101. PubMed ID: 2318158
[TBL] [Abstract][Full Text] [Related]
10. The competitive antagonistic effect of compounds from Mandevilla velutina on kinin-induced contractions of rat uterus and guinea-pig ileum in vitro.
Calixto JB; Pizzolatti MG; Yunes RA
Br J Pharmacol; 1988 Aug; 94(4):1133-42. PubMed ID: 3207977
[TBL] [Abstract][Full Text] [Related]
11. Design of novel bicyclic analogues derived from a potent oxytocin antagonist.
Flouret G; Chaloin O; Borovickova L; Slaninová J
J Pept Sci; 2006 Jun; 12(6):412-9. PubMed ID: 16432806
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological effects and metabolism of neurotensin and bradykinin in the isolated rat uterus.
Lebrun I; Camargo AC; Correa FM
Eur J Pharmacol; 1988 Mar; 148(2):231-7. PubMed ID: 3378572
[TBL] [Abstract][Full Text] [Related]
13. The expression of functionally-coupled B2-bradykinin receptors in human corneal epithelial cells and their pharmacological characterization with agonists and antagonists.
Wiernas TK; Griffin BW; Sharif NA
Br J Pharmacol; 1997 Jun; 121(4):649-56. PubMed ID: 9208130
[TBL] [Abstract][Full Text] [Related]
14. Lysine vasopressin-induced increases in porcine myometrial contractility and intracellular Ca2+ concentrations of myometrial cells: involvement of oxytocin receptors.
Yu H; Zhuge R; Hsu WH
Biol Reprod; 1995 Mar; 52(3):584-590. PubMed ID: 7756452
[TBL] [Abstract][Full Text] [Related]
15. Progress in the development of oxytocin antagonists for use in preterm labor.
Pettibone DJ; Guidotti M; Harrell CM; Jasper JR; Lis EV; O'Brien JA; Reiss DR; Woyden CJ; Bock MG; Evans BE
Adv Exp Med Biol; 1995; 395():601-12. PubMed ID: 8714024
[TBL] [Abstract][Full Text] [Related]
16. Kinin antagonist activity of compounds from Mandevilla velutina in the rat isolated uterus.
Calixto JB; Nicolau M; Pizzolatti MG; Yunes RA
Br J Pharmacol; 1987 May; 91(1):199-204. PubMed ID: 3594076
[TBL] [Abstract][Full Text] [Related]
17. Action of pregnane compounds from Mandevilla illustris against contractions induced by kinins and other oxytocics in the rat isolated uterus.
Calixto JB; Brum RL; Yunes RA
Gen Pharmacol; 1991; 22(6):1071-5. PubMed ID: 1810805
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
Chen YL; Shepherd C; Spinelli W; Lai FM
Eur J Pharmacol; 1999 Jul; 376(1-2):45-51. PubMed ID: 10440088
[TBL] [Abstract][Full Text] [Related]
19. Improvement in potency of an oxytocin antagonist after systematic substitutions with L-tryptophan.
Flouret G; Brieher W; Majewski T; Mahan K; Wilson L
J Med Chem; 1991 Jul; 34(7):2089-94. PubMed ID: 2066980
[TBL] [Abstract][Full Text] [Related]
20. Comparison of binding affinity of oxytocin antagonists to human and rat uterine oxytocin receptors and their correlation to the rat uterine oxytocic bioassay.
Pak SC; Bertoncini D; Meyer W; Scaunas D; Flouret G; Wilson L
Biol Reprod; 1994 Dec; 51(6):1140-4. PubMed ID: 7888492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
